Linus Biotechnology
Signal active
Organization
Contact Information
Overview
Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine. It is focuses on complex genomic diseases that helps provide clients with the technology for the analysis of genomic sequencing data.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2020
Employees
11-50
Headquarters locations
New York, United States, North America
Social
N/A
Profile Resume
Linus Biotechnology headquartered in New York, United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $1.1B in funding across 36 round(s). With a team of 11-50 employees, Linus Biotechnology is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Linus Biotechnology, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$31.6M
Details
3
Linus Biotechnology has raised a total of $31.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 1.5M | ||
| 2023 | Early Stage Venture | 16.0M | ||
| 2023 | Early Stage Venture | 8.0M |
Investors
Linus Biotechnology is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sanford Robertson | - | FUNDING ROUND - Sanford Robertson | 16.0M |
| David Bellet Family Office | - | FUNDING ROUND - David Bellet Family Office | 16.0M |
| Linus Biotechnology | - | FUNDING ROUND - Linus Biotechnology | 16.0M |
| Gillian Sandler | - | FUNDING ROUND - Gillian Sandler | 16.0M |
Recent Activity
There is no recent news or activity for this profile.